Johnson & Johnson (JNJ)

$146.97 1.06 (0.72%)

17:10 EDT JNJ Stock Quote Delayed 30 Minutes

Volume:

Previous Close $148.03

Market Cap 394.20B

PE Ratio 319.50

EPS 0.46

Volume (Avg. Vol.) 6.38M

Day's Range 146.37 - 149.23

52-Week Range 109.16 - 157.00

Dividend & Yield 3.48 (2.37%)

JNJ Stock Predictions, Articles, and Johnson & Johnson News

From InvestorPlace
From the Web

5 Biotech Stocks That Offer Long-Term Growth and Value

By Faizan Farooque Aug 6, 2020

Biotech stocks are on fire at the moment. That said, here are five names from the sector that offer long-term value and strong fundamentals.

The Best Dividend Stocks to Buy in 9 Sectors

By Josh Enomoto, InvestorPlace Contributor Aug 6, 2020

With seemingly everyone bidding up growth firms, it’s easy to forget about dividend stocks. However, you shouldn’t ignore these relatively reliable, passive income-paying companies.

5 Dental Stocks to Buy For Big Smiles As Coronavirus Fears Ease

By Todd Shriber, InvestorPlace Contributor Jul 29, 2020

Dental stocks offer some risk, but some members of this industry have exciting growth prospects, particularly when Covid-19 is erased.

4 Top Blue-Chip Stocks for Peace of Mind

By Vince Martin, InvestorPlace Contributor Jul 21, 2020

In an uncertain market, investors should focus on blue-chip stocks. Here are four such names with solid valuations and downside protection.

3 Best Long-Term Stocks to Set and Forget

By Todd Shriber, InvestorPlace Contributor Jul 17, 2020

When investing for the long-term, investors should prize stocks with strong management, wide moats and plenty of growth levers.

JNJ Stock: 4 Things to Know About Johnson & Johnson Q2 Earnings

By William White, InvestorPlace Writer Jul 16, 2020

Johnson & Johnson (JNJ) earnings for Q2 2020 have the pharmaceutical and consumer goods company's stock on the move Thursday.

Compare Brokers

Quick Income from a Put Write on Johnson & Johnson

By Ken Trester, Editor, Power Options Weekly Jul 14, 2020

Earnings season is upon us, and Johnson & Johnson (NYSE:JNJ) will kick off second-quarter reporting for the big pharmaceutical stocks on July 16.

With Earnings in Sight, Johnson & Johnson Stock Looks Perfectly Healthy

By David Moadel, InvestorPlace Contributor Jul 14, 2020

While the media is busy focusing on talc-based products, let's not ignore the positive catalysts that could take JNJ stock to the next level.

4 Pharmaceutical Stocks to Watch for the Rest of 2020

By Faisal Humayun Jul 7, 2020

As pharmaceutical companies rush to manufacture coronavirus vaccine and drugs, it makes sense to hold some potential winners.

The Top 7 Healthcare Stocks You Should Be Watching

By Ian Bezek, InvestorPlace Contributor Jun 30, 2020

The healthcare industry has historically delivered market-beating returns. And the current pandemic has created new opportunities in the sector.

9 All-Around Dividend Stocks to Tough It Out

By Josh Enomoto, InvestorPlace Contributor Jun 29, 2020

The best dividend stocks offer viable options that vary by investment style ... but these stocks that pay dividends are for everyone!

10 Recession-Proof Stocks to Weather the Storm

By Josh Enomoto, InvestorPlace Contributor Jun 25, 2020

Should the economy not bounce back following the coronavirus, you’ll want to look at these recession-resistant stocks to buy.

Compare Brokers

3 Dow Jones Companies to Buy as Markets Get Volatile

By Tezcan Gecgil, InvestorPlace Contributor Jun 18, 2020

After an impressive rally from March lows, many stocks may be ready to take a breather. Yet there are several Dow Jones companies to buy as volatility returns to the market.

3 Top Healthcare Stocks for a More Aware World

By Faisal Humayun Jun 17, 2020

Even after the novel coronavirus is contained, healthcare stocks will remain in focus. Good time to accumulate stocks with strong growth outlook.

5 Cheap Growth Stocks With Attractive Dividend Yields

By Mark R. Hake, CFA Jun 15, 2020

These cheap GARP stocks have huge upside potential with attractive yields, and wise investors should not ignore them.

7 Pharmaceutical Stocks to Buy for Post-Pandemic Gains

By Louis Navellier and the InvestorPlace Research Staff, Editor, Growth Investor Jun 9, 2020

Much of the conversation about pharmaceutical stocks rests on the coronavirus, but these high-growth names have potential beyond the pandemic.

The Best 5 Stocks to Buy on the Next Dip

By Thomas Niel Jun 2, 2020

Taking a look at major names, these five stand out as stocks to buy on the dip: Alphabet (NASDAQ:GOOG,NASDAQ:GOOGL) AT&T (NYSE:T) Johnson & Johnson (NYSE:JNJ) Microsoft (NASDAQ:MSFT) Starbucks (NASDAQ:SBUX) Granted, FUD (fear, uncertainty, and doubt) remain, even as markets trend higher. But, the relative strengths of these 5 names could make them buys on a pullback. Let's dive in, and find out why.

7 Dow Jones Stocks to Buy With Fortress-Like Balance Sheets

By Will Ashworth, InvestorPlace Contributor May 21, 2020

Several billionaire investors believe the markets are overvalued. Here are seven Dow Jones stocks to buy in this uncertain environment.

Compare Brokers

Dow Jones Today: Pent Up Demand and Reopening in Sight

By Todd Shriber, InvestorPlace Contributor May 20, 2020

While rejuvenating consumer confidence and consumption could take awhile in the wake of the novel coroanvirus, markets are betting that rebound will happen as highlighted by 25 of 30 Dow stocks trading higher in late trading.

Dow Jones Today: Vaccine News And Fed Talk Powered Markets Higher

By Todd Shriber, InvestorPlace Contributor May 18, 2020

Moderna, a stock that doesn't reside in the Dow Jones Industrial Average, sent the blue chip index soaring to start the week.

Navellier Ratings

Total Grade

Buy

Johnson & Johnson (JNJ)

JNJ Stock Predictions, Articles, and Johnson & Johnson News

Navellier Ratings

Total Grade

Subscriber Sign in